Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis

Samar M. Said, Sanjeev Sethi, Anthony M. Valeri, Anthony Chang, Cynthia C. Nast, Leslie Krahl, Peter Molloy, Marc Barry, Mary E. Fidler, Lynn D. Cornell, Nelson Leung, Julie A. Vrana, Jason D. Theis, Ahmet Dogan, Samih H. Nasr

Research output: Contribution to journalArticle

43 Scopus citations

Abstract

Amyloidosis derived from leukocyte chemotactic factor 2 (ALECT2) is a recently described disease. Here, we report the characteristics and outcome of 72 patients with renal ALECT2, which included 19 who had another kidney disease on biopsy. Ninety-two percent of patients were Hispanics and over half were elderly. Three had other organ, but not cardiac, amyloidosis involvement. All patients without concurrent disease, except three, presented with chronic renal insufficiency. Proteinuria was variable and absent in a third, whereas nephrotic syndrome and hematuria were rare. After a median follow-up of 26 months, one-third developed end-stage renal disease (ESRD). The median renal survival was 62 months. Independent predictors of renal survival were serum creatinine at diagnosis, with a value of 2.0 mg/dl being the best cutoff for predicting ESRD, percentage global glomerulosclerosis, and presence of diabetes. Only four patients died and four had received chemotherapy for an erroneous diagnosis of immunoglobulin light chain-derived amyloidosis. Five patients underwent kidney transplantation; none had graft loss but one had disease recurrence. Patient survival is superior to renal immunoglobulin light chain-derived amyloidosis and reactive amyloidosis largely due to the absence of cardiac involvement. Thus, renal ALECT2 mainly affects elderly Hispanics who typically present with chronic renal insufficiency and bland urine sediment, with or without proteinuria.

Original languageEnglish (US)
Pages (from-to)370-377
Number of pages8
JournalKidney international
Volume86
Issue number2
DOIs
StatePublished - Aug 2014

Keywords

  • mass spectrometry
  • nephrology
  • proteinuria
  • renal biopsy
  • transplant outcomes

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis'. Together they form a unique fingerprint.

  • Cite this

    Said, S. M., Sethi, S., Valeri, A. M., Chang, A., Nast, C. C., Krahl, L., Molloy, P., Barry, M., Fidler, M. E., Cornell, L. D., Leung, N., Vrana, J. A., Theis, J. D., Dogan, A., & Nasr, S. H. (2014). Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis. Kidney international, 86(2), 370-377. https://doi.org/10.1038/ki.2013.558